CLOPIDOGREL AUROBINDO 75 mg Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

clopidogrel aurobindo 75 mg

apl swift services (malta) limited - malta - clopidogrelum - compr. film. - 75mg - antitrombotice antiagregante plachetare

Ondansetron 2 mg/ml soluție injectabilă Մոլդովա - ռումիներեն - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

ondansetron 2 mg/ml soluție injectabilă

centrul Ştiinţific de producere "uzina chimico-farmaceutică borsceagov" sap - ondansetronum - soluție injectabilă - 2 mg/ml

Ondansetron 2 mg/ml soluţie injectabilă Մոլդովա - ռումիներեն - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

ondansetron 2 mg/ml soluţie injectabilă

centrul Ştiinţific de producere "uzina chimico-farmaceutică borsceagov" sap - ondansetronum - soluţie injectabilă - 2 mg/ml

Locametz Եվրոպական Միություն - ռումիներեն - EMA (European Medicines Agency)

locametz

novartis europharm limited  - gozetotide - radionuclide imaging - produse radiofarmaceutice de diagnosticare - acest medicament este destinat exclusiv diagnosticului. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.